BGI Statement in Response to Reuters Report

SHENZHEN, China, July 9, 2021 /PRNewswire/ -- BGI is aware of reports in Reuters regarding the company’s non-invasive prenatal test (NIPT test) - NIFTY (Non-Invasive Fetal TrisomY). BGI’s NIPT tests (one kind of BGI gene test) have been used around the world to identify ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:02:40 ]

China Genomics Giant Drops Plans for Gene-Edited Pets

China’s largest BGI gene test company is going public. But hold the bacon. Starting this week, investors should be able to buy shares in BGI, China’s largest genomics company, as it completes a $251 million initial public offering. But if you were hoping to get your hands ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:02:19 ]

BGI is granted patent in 16 countries for non-invasive prenatal genetic test technology

BGI Dx has developed a series of BGI gene test services based on multidisciplinary technologies and approaches, including independent core technologies such as high throughput sequencing, high sensitivity mass spectrum and big data analysis. BGI Dx\'s test product provision ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:01:56 ]

Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq Technology Platform

SAN CARLOS, Calif. and SHENZHEN, China, March 11, 2019 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA genetic testing, and BGI Genomics Co., Ltd., (300676.SZ), the largest cell-free DNA clinical testing laboratory in China and one of the ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:01:29 ]

BGI Genomics

BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:01:07 ]

BGI Genomics H1 Revenues Fall 11 Percent on COVID-19 Testing Decline

NEW YORK – Chinese diagnostics firm BGI Genomics reported last week that its H1 2021 revenues declined 11 percent due to decreasing demand for COVID-19 testing. Total revenues were RMB 3.6 billion ($560 million), down from RMB 4.1 billion in the same period last year. The ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:00:42 ]

BGI Genomics Sees Diagnostics Core Business Rebounding, Overseas Business Growing

NEW YORK – BGI Genomics has seen growth in several areas of its core diagnostic testing business during the first half of 2021 and is working on upgrading its tests in reproductive health. Late last month, the publicly traded clinical BGI gene test and research services arm ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 17:00:14 ]

The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing

Introduction: The sequencing-based noninvasive BGI prenatal test has been successfully integrated into clinical practice and facilitated the early detection of fetal chromosomal anomalies. However, a comprehensive reference material to evaluate and quality control NIPT services ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:59:51 ]

Global Non-Invasive Prenatal Testing (NIPT) Market 2020-2031: Focus on Method, Test, Platform, End-user, Application and Country - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The \"Global Non-Invasive BGI prenatal test Market: Focus on Method, Test, Platform, End User, Application and Country Analysis and Forecast, 2020-2031\" report has been added to ResearchAndMarkets.com\'s offering. The global NIPT market was valued at ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:59:26 ]

BGI Genomics, Genoks Team to Expand Genetic Testing in Turkey

BGI Genomics and the Turkish genomics healthcare company Genoks have inked a new memorandum of understanding (MOU) broadening their existing partnership in the field of noninvasive BGI prenatal test. The updated MOU commits BGI Genomics to provide full technical and strategic ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:58:58 ]

Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA

Abstract of BGI prenatal test Objectives The aim of this study was to assess the performance of noninvasively prenatal testing (NIPT) for fetal copy number variants (CNVs) in clinical samples, using a whole-genome sequencing method. Method A total of 919 archived maternal ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:58:30 ]

The Nifty Test for Pregnant Women: Non-Invasive Prenatal Testing

At BGI there aim is to apply their high genetic research capacity and well-developed global network to solving current health issues worldwide. They are committed to raising genetic health awareness and reducing the rate of major disease by offering a broad array of accurate, ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:58:04 ]

Noninvasive prenatal diagnosis of hemophilia A by a haplotype-based approach using cell-free fetal DNA

Abstract of BGI prenatal test Aim: We aimed to demonstrate noninvasive prenatal diagnosis (NIPD) of hemophilia A (HA) using a haplotype-based approach. Methods: Two families at risk for HA were recruited for this study. First, maternal haplotypes associated with pathogenic ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:57:41 ]

BGI is granted patent in 16 countries for non-invasive prenatal genetic test technology

Patent for non-invasive BGI prenatal test granted by European Patent Office and State Intellectual Property Office of China October 10, 2014, Shenzhen, China-- The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:57:17 ]

Genomic Analyses from Non-invasive Prenatal Testing Reveal Genetic Associations, Patterns of Viral Infections, and Chinese Population History

We analyze whole-genome sequencing data from 141,431 Chinese women generated for non-invasive BGI prenatal test (NIPT). We use these data to characterize the population genetic structure and to investigate genetic associations with maternal and infectious traits. We show that ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:56:54 ]

About BGI

BGI, founded in 1999 with the vision of using genomics to benefit the human race, is now the world’s largest genomics organisation. BGI includes both private non-profit research institutes and sequencing application commercial units. Together with its affiliated offshoots, ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:56:29 ]

China's BGI and Huawei partner on Big Data genomic system storage

BGI China High-profile China genomic sequencing company BGI and telecom network manufacturer and services company Huawei Technology plan a massive data-storage system for genomic research to achieve \"an over 30% improvement in the overall efficiency of genome sequencing ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:56:08 ]

Bgi Genomics Co., Ltd.

Overview of BGI China Doing Business As: Bgi Genomics Co., Ltd. Company Description: Bgi Genomics Co., Ltd. is located in Shenzhen, Guangdong, China and is part of the Scientific Research and Development Services Industry. Bgi Genomics Co., Ltd. has 3,778 total employees across ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:55:40 ]

China's gene-sequencing giant BGI to join UAE genome project

BGI China China\'s top gene-sequencing provider BGI will participate in the Genome Program, which aims to use genomic data to improve health outcomes in the United Arab Emirates (UAE), the company announced Wednesday. The program plans to use large-scale genomic data to ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:55:07 ]

A Chinese Genome Giant Sets Its Sights on the UItimate Sequencer

THE WORLD’S LARGEST genetics research center isn’t at Harvard or Stanford or even the NIH. It’s a 20-mile drive from Hong Kong International Airport, in the bustling Chinese city of Shenzhen. BGI (BGI China)---formerly the Beijing Genomics Institute---has sequenced the ...

BGI Genomics    [Business Services]   [Other Business Services]   [2022-04-22 16:54:43 ]